Skip to content
Significant reduction in heart rate variability is a feature of acute decompensation of cirrhosis and predicts 90‐day mortality

Document -

Significant reduction in heart rate variability is a feature of acute decompensation of cirrhosis and predicts 90‐day mortality

This study demonstrates that remote wireless HRV monitoring identifies cirrhosis patients at high risk of developing ACLF and death, and suggests such monitoring might guide the need for early intervention in such patients.
  • License: Media Use
    The content may be downloaded by journalists, bloggers, columnists, creators of public opinion, etc. It can be used and shared in different media channels to convey, narrate, and comment on your press releases, posts, or information, provided that the content is unmodified. The author or creator shall be attributed to the extent and in the manner required by good practice (this means, for example, that photographers should be attributed).
  • File format: .pdf
Download

Subjects

Tags


Isansys is the world's leading digital healthcare company which has developed an innovative patient monitoring platform, enabling early detection of deterioration in patients. We are a business focussed on driving disruptive technologies into hospitals and healthcare organisations globally providing health professionals with the vital tools required to improve patient care and increase clinical performance, ensuring economic value and enhancing patient safety. For further information and to stay updated on our latest news visit www.isansys.com, follow us on Twitter at @isansys or subscribe to our YouTube Channel at www.youtube.com/isansyslifecare

Press contacts

Georgina Horton

Georgina Horton

Press contact PR and Marketing Executive 01235 436225